The global fight against tuberculosis

Medical research is one of the most important outputs for a university, with breakthroughs potentially saving lives around the world. Professor Stephen Gillespie and colleagues at the School of Medicine have done just this, developing global capacity to improve tuberculosis treatment by developing shorter, safer drug regimens, and improved diagnostics for monitoring treatment. Heat map of tuberculosis …

30th September 2021 | igh


European Society for Clinical Microbiology and Infectious Diseases Symposium

Stephen Gillespie joined distinguished international colleagues on a European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Symposium “Tuberculosis: Bringing new science to diagnostics”.  Speaking were Professors Ulrika Simmonson from University of Uppsala (Pharmacometrics) Jan-Willem Alffenaar from the University of …

19th May 2021 | igh


World TB Day – 24 March 2021

Globally, Tuberculosis (TB) is the leading cause of death from a single infectious disease agent.  Our sustained research in St Andrews over the last 10 years (on the disease and the pathogen responsible) has developed global capacity to improve tuberculosis …

24th March 2021 | igh


Covid-19 – Ask the experts

During April and May 2020, ‘three ask the expert’ sessions were held for staff to answer their queries on Covid-19. These were introduced by Prof Stephen Gethins. The panel included Prof Stephen Gillespie and Dr Devesh Dhasmana from the division …

20th April 2020 | Covid-19


Longitude Prize

The Orbital Diagnostics team is in the running for the £8 million Longitude Prize for their SLIC device.

15th November 2018 | news


New trial to combat TB

Scientists at the School of Medicine are leading the medical monitoring of a new clinical trial to treat tuberculosis more quickly.

5th September 2018 | news


Innovative diagnostic test for tuberculosis could save millions of lives

LifeArc and the Infection Group, led by Professor Stephen Gillespie announced a partnership to develop a molecular diagnostic test for the detection and quantification of tuberculosis (TB) bacteria in patients.

8th August 2018 | news


MBLA Conference

the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.

25th June 2018 | news


MBLA Conference

Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.

13th June 2018 | news


SLIC wins another award!

The Orbital diagnostics team won the innovation of the year award at the Scottish Enterprise Life Science awards.

17th May 2018 | news